Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer. - Wikidata - wikimedia - TriplyDB

Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.

Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.

http://www.wikidata.org/entity/Q39505285

about

Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer Small Non-coding Transfer RNA-Derived RNA Fragments (tRFs): Their Biogenesis, Function and Implication in Human Diseases Beyond the Ribosome: Extra-translational Functions of tRNA Fragments Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism Genome-wide analysis of microRNA and mRNA expression signatures in cancer tRNA fragments in human health and disease The mutational landscape of prostate cancer Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential Long Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical Translation Genomic-Wide Analysis with Microarrays in Human Oncology Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapy Bioinformatics of Cancer ncRNA in High Throughput Sequencing: Present State and Challenges Genomic sequencing in clinical trials miRNAs associated with prostate cancer risk and progression miRDeep*: an integrated application tool for miRNA identification from RNA sequencing data.MicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samples Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer Noncoding RNAs in endocrine malignancy New frontiers in translational control of the cancer genome Noncoding RNAs as novel biomarkers in prostate cancer.Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma.Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.Expression of lysophosphatidic acid receptor 1 and relation with cell proliferation, apoptosis, and angiogenesis on preneoplastic changes induced by cadmium chloride in the rat ventral prostate Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology Coordinate microRNA-mediated regulation of protein complexes in prostate cancer.Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs.Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis.snoRNAs are a novel class of biologically relevant Myc targets.A central role for long non-coding RNA in cancer Genomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers.Correlation of Global MicroRNA Expression With Basal Cell Carcinoma Subtype.Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer.

P2860

Q21133676-0DAB1326-B35A-4C45-8C9A-EA506F90624B Q26751983-EBFC6057-F32D-4E9C-A876-BCA10B673DE9 Q26766672-858E0077-9E15-4EC2-A09E-18AF780CC08A Q26769608-6A9B6276-EC8C-45B7-A619-FA1C405BA6A3 Q26774456-FA3B4F9F-6D23-4099-BC56-11A751EE664A Q26795603-414D8F97-BC7D-4722-99AB-E5A9760896E9 Q26824181-EF6BE9A5-56A4-4E1F-9CA9-DEDC0ECC5D42 Q26851631-DCA9F992-44A4-4FC6-8F03-CC9F5658938C Q27016076-DD1324CF-D4FA-4CC3-BD31-7122AC68DF3C Q27022638-08FF3B2E-3228-45EC-B538-3BC8944340D1 Q28071872-1AB7AA06-D934-460C-A808-446419C8476C Q28081059-108F4E90-3190-4EC7-B614-CC6202298B3C Q28118790-63A3D177-743C-47B8-856B-926299F0DADB Q28543958-B8201EED-A7CB-4ECE-A882-374A625CD93F Q28710308-9C152C8A-FA66-488B-A514-6F858F4BDE01 Q28732333-D99ABE53-35EA-479C-942B-D59BEA06051D Q30235186-23765F9E-E28E-468B-9AC6-B29F431AC772 Q30580665-29B3CF99-B11C-46BF-AE26-F9D6D2FF2A15 Q30859743-82B01DC6-9575-46CF-B0F4-431981B6E755 Q31119968-2DC4A747-71A9-451C-A036-DCBAE66E4CA2 Q33577889-1310025E-563B-4638-8D06-57A293E777A9 Q33853235-EC68A676-2EC5-4664-BB20-FABA353B1B47 Q34176890-CF86031B-246C-4F74-AE0C-A98EF1B25749 Q34248844-5AA945BA-A76B-4899-9F4C-F86A06BBC70B Q34354560-FA73D4D5-FB12-443C-9632-6FA1200E6150 Q34489344-7C5AD628-A2A7-4144-B143-0B9A0598E3BD Q34540405-BA13F52E-7320-4112-AEEC-C25638508CB7 Q34603802-6F8EAB48-10A1-48E8-81CC-F3E9C674B4A0 Q34605730-12A6A001-34DF-4A6C-A241-1EE61F93ACF6 Q35082892-34D1FC3D-0A91-496A-BF6F-BB7186AC1F4A Q35092050-48985F58-AF66-4A22-82DD-C68DA761F86D Q35110766-1A66AEFA-6758-4860-AB5A-386F70B00CFB Q35544302-2505C0CD-C61F-4337-A93A-2A09A4A9890D Q35573029-4054F958-A27D-41CD-AAC7-A4071EBB0058 Q35604143-DB69B104-54C7-447A-B39C-EEEAB85876D9 Q35757646-08EFD2C2-2522-4A4C-BD75-D8F622CE9A9B Q35771477-07124F61-8BB8-4C69-8036-2CA969DCA084 Q35771697-D8AB528E-7011-4A0B-9BD4-9931A4EF7D35 Q35814277-F117D436-5187-4CCC-944A-39C4102CD4E7 Q35906143-FBDB6A28-7051-48DF-9F40-61B3C5FD42D1

P2860

Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.

http://www.wikidata.org/entity/Q39505285

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Diagnostic and prognostic sign ...... nscriptome in prostate cancer.

@en

Diagnostic and prognostic sign ...... nscriptome in prostate cancer.

@nl

type

label

Diagnostic and prognostic sign ...... nscriptome in prostate cancer.

@en

Diagnostic and prognostic sign ...... nscriptome in prostate cancer.

@nl

prefLabel

Diagnostic and prognostic sign ...... nscriptome in prostate cancer.

@en

Diagnostic and prognostic sign ...... nscriptome in prostate cancer.

@nl

P1433

Q39505285-16F7964F-70AA-4449-BA1B-1DD4231E041F

P1476

Q39505285-3D5296B7-F196-4709-9101-55EA1ACA7B66

P2093

Q39505285-0CA3A2DC-EE1D-4754-B203-C221F344D601

Q39505285-2D277051-BC3D-488B-A82B-302775986620

Q39505285-3D7823BE-50D4-4745-B99D-9E20D1CF96C4

Q39505285-54146A5C-0FA3-4547-84ED-914FBC06399B

Q39505285-5D69808B-343A-4D93-8DD1-0FB80B755477

Q39505285-65969F7D-4F92-432F-8833-C0A558664E1A

Q39505285-823091C0-641E-4F2E-B5F5-EB84AFA5CBC5

Q39505285-BA847D6A-A974-4CDF-AA6F-6AB3063D87E1

Q39505285-CBD19B60-C64B-4AAE-8E75-854585FDB33F

Q39505285-F284B277-E5BC-4A1F-A61A-19C8CC478C34

P2860

Q39505285-00227EEB-E787-490A-82A2-C52CC06A27BE

Q39505285-0622C8A9-4812-4D67-8A5C-30ED82457A66

Q39505285-0DF26E13-378A-4F5B-BA22-66E5278EC395

Q39505285-10BAB020-C193-4598-BC32-48E5F4EC7DD6

Q39505285-20B19B9E-26F1-455D-B4CF-BC8EC68D63CE

Q39505285-2683FEE9-611E-4FC1-BD55-DC984EDBF33B

Q39505285-31C0B199-5991-4729-96E9-19582E5908EA

Q39505285-31EFCD90-1088-4143-A1DB-E2C8698E3209

Q39505285-38DF2215-A091-4699-A989-17B5B6679B6C

Q39505285-3A071929-2BEA-4C0D-A8F0-B55E75D0E216

P2888

Q39505285-C746CC3E-F4D4-4027-ACC0-80178F32B938

P304

Q39505285-F5B4AFA1-65E5-4868-B022-10B8F7393DD2

P31

Q39505285-78BB2788-6238-4AA7-B2EA-1AFA2634BDAC

P356

Q39505285-A0C27BF6-A8DB-4713-9B7C-242023C4119B

P407

Q39505285-5D4BBDA1-C63E-4063-A6D0-E146DC41000C

P433

Q39505285-8B742FBC-BDA2-44A7-AFB6-CAFD483F93C7

P478

Q39505285-F19B6DD7-00ED-4BD0-B160-22A6E661E3C6

P577

Q39505285-758D5892-F5C6-48EA-A8C8-2AC8C15A898C

P5875

Q39505285-BA57ED85-3E57-4AD9-826D-BD6B30499E2A

P6179

Q39505285-3868D71C-5063-4797-AA9E-B455BDB862BE

P698

Q39505285-AC217297-1A65-47A9-AC9C-616CF1BBB041

P921

Q39505285-6A10513F-5FE8-46B6-9385-279929CB3752

Q39505285-788e6e06-524f-40ca-9488-0dd43c349422

Q39505285-B4AFCC0B-B090-4FAC-9846-0FC854389B12

P356

P1433

P1476

Diagnostic and prognostic sign ...... nscriptome in prostate cancer.

@en

P2093

C H Bangma

http://www.w3.org/2001/XMLSchema#string

E S Martens-Uzunova

http://www.w3.org/2001/XMLSchema#string

G J L H van Leenders

http://www.w3.org/2001/XMLSchema#string

G Jenster

http://www.w3.org/2001/XMLSchema#string

J Trapman

http://www.w3.org/2001/XMLSchema#string

N F Dits

http://www.w3.org/2001/XMLSchema#string

S E Jalava

http://www.w3.org/2001/XMLSchema#string

S Møller

http://www.w3.org/2001/XMLSchema#string

T Litman

http://www.w3.org/2001/XMLSchema#string

T Visakorpi

http://www.w3.org/2001/XMLSchema#string

P2860

A microRNA expression signature of human solid tumors defines cancer gene targets

Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells

The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis

MicroRNA expression profiles classify human cancers

Small RNAs derived from snoRNAs

The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C

P2888

P304

978-991

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2011.304

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51498706

http://www.w3.org/2001/XMLSchema#string

P6179

1045154711

http://www.w3.org/2001/XMLSchema#string

P698

21765474

http://www.w3.org/2001/XMLSchema#string

P921